Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$2.15 - $3.5 $63,446 - $103,285
-29,510 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$2.77 - $6.17 $39,611 - $88,231
-14,300 Reduced 32.64%
29,510 $84,000
Q2 2020

Aug 14, 2020

SELL
$0.87 - $3.13 $38,019 - $136,781
-43,700 Reduced 49.94%
43,810 $136,000
Q1 2020

May 15, 2020

SELL
$0.73 - $1.91 $15,914 - $41,638
-21,800 Reduced 19.94%
87,510 $83,000
Q4 2019

Feb 14, 2020

BUY
$0.48 - $1.38 $52,468 - $150,847
109,310 New
109,310 $151,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.